Xylyx Bio, Inc. is a regenerative medicine company harnessing systemic physiology into paradigm-shifting tissue and organ repair technologies.

BIOCOMX is a not-for-profit organization whose primary mission is to train researchers, professionals and early stage companies in commercializing medical technologies. Scientists and engineers go through a rigorous process of idea and technology validation as they pursue their passion to bring the latest biomedical innovations to the market.

Columbia’s Biomedical Accelerator catalyzes the advancement of biomedical innovations by providing funding, education, resources, and mentorship to interdisciplinary teams of clinicians, engineers, and scientists working to develop solutions to clinical unmet needs, with the ultimate goal of bringing innovative research out of the lab to benefit society.